Head External News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Uganda Baati donates office units to Police, Directorate of Industrial Training

Uganda Baati donates office units to Police, Directorate of Industrial Training
kfm.co.ug - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kfm.co.ug Daily Mail and Mail on Sunday newspapers.

Kirungi suleimanIan rumanyikaSafal uganda baati foundationCorporate affairsUganda policeUganda baatiIndustrial trainingHead externalHajji kirungi suleiman

Santhera Pharmaceuticals Holding AG: Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference

Pratteln, Switzerland, and Rockville, MD, USA, March 15, 2022 - Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of efficacy and tolerability data with vamorolone

Switzerland generalUnited statesUnited kingdomRyman hallEric hoffmanEva kaliasReveragen biopharmaMuscular dystrophy associationReveragen biopharma incSanthera pharmaceuticalsMuscular dystrophy association united statesNational institutes of healthHead external communicationsDuchenne research fundFoundation to eradicate duchenneSanthera pharmaceuticals holding

Santhera Completes Ordinary Capital Increase to Create

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement.

Switzerland generalUnited statesEva kaliasSanthera pharmaceuticalsHead external communicationsChiesi groupSwiss exchangeNorth americaHead externalSwiss stock exchange sannSanthera pharmaceuticals holding ag

Santhera Pharmaceuticals Holding AG: Santhera Completes Ordinary Capital Increase to Create Treasury Shares for Future Financing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland

Switzerland generalUnited statesEva kaliasSanthera pharmaceuticalsHead external communicationsChiesi groupSwiss exchangeSanthera pharmaceuticals holdingNorth americaHead externalSecurities act

Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference

Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference  Pratteln, Switzerland, and Rockville, MD, USA, March 15, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of efficacy and tolera.

Switzerland generalUnited statesUnited kingdomRyman hallEric hoffmanEva kaliasReveragen biopharmaMuscular dystrophy associationReveragen biopharma incSanthera pharmaceuticalsNational institutes of healthMuscular dystrophy association united statesHead external communicationsDuchenne research fundFoundation to eradicate duchenneSanthera pharmaceuticals holding